Makale detayı · 2021 · article
Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells
ISSN1773-2247
YÖKSİS
OpenAlex
Yıl2021
Atıf50OpenAlex
Atıf46Semantic Scholar · 1 etkili
Yüzdelik%86,6
FWCI2,081,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q2
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıJournal of Drug Delivery Science and Technology
- Katalog eşleşmesi (ISSN)Journal of Drug Delivery Science and Technology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
50atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 26 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2022 Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancerAtıf 60 · OpenAlex
- 2022 Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancerAtıf 60 · OpenAlex
- 2023 Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapyAtıf 56 · OpenAlex
- 2023 Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapyAtıf 56 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 14 · OpenAlex
- 2024 An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticlesAtıf 13 · OpenAlex